Financial Consulate’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.48M Sell
1,232
-13
-1% -$13.3K 0.16% 38
2026
Q1
$1.15M Buy
1,245
+10
+0.8% +$10.1K 0.14% 43
2025
Q4
$1.33M Buy
1,235
+6
+0.5% +$5.74K 0.18% 38
2025
Q3
$938K Buy
+1,229
New +$915K 0.13% 54
2023
Q2
Sell
-820
Closed -$282K 82
2023
Q1
$282K Buy
820
+248
+43% +$83.6K 0.1% 101
2022
Q4
$209K Buy
+572
New +$203K 0.07% 129

Other funds holding LLY

Financial Consulate's LLY Position: Q2 2026 in Review

Financial Consulate reduced its Eli Lilly (LLY) stake by 1% in Q2 2026, selling an estimated $13.3K and leaving 1,232 shares worth $1.48M. The position accounts for 0.16% of the portfolio, ranked #38.

Financial Consulate first reported a position in LLY in Q4 2022 and has held it in 6 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Financial Consulate held 1,232 shares of Eli Lilly worth $1.48M as of Q2 2026.
  • Financial Consulate sold 13 Eli Lilly shares in Q2 2026, an estimated $13.3K.
  • Eli Lilly made up 0.16% of Financial Consulate's portfolio in Q2 2026, its #38 holding.
  • Financial Consulate first reported a position in Eli Lilly in Q4 2022 and has held it in 6 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Financial Consulate's 13F filing for Q2 2026, filed 23 Jul 2026.